Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68071-3943

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68071-3943). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3943 1)

Pdp (68071 3943 1)
Metoprolol Succinate 50 mg Extended-Release Tablets label from NuCare Pharmaceuticals, Inc. The label shows NDC 68071-3943-1, with 100 tablets per container. Each tablet contains 47.5 mg Metoprolol Succinate equivalent to 50 mg Metoprolol Tartrate. Manufactured by Visum Pharmaceutical Co., Ltd., Haikou, China.*
FDA Label Image

Figure (Figure001)

Figure (Figure001)
A forest plot titled 'Results for Subgroups in MERIT-HE' showing relative risk and 95% confidence intervals for various subgroups related to Metoprolol Succinate Extended-Release Tablets. The plot includes three panels comparing total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure, with data segregated by demographic and clinical factors such as region, NYHA class, ejection fraction, etiology, sex, race, previous myocardial infarction, diabetes, hypertension, and heart rate.*
FDA Label Image

Structure (Structure001)

Structure (Structure001)
Chemical structure diagram of Metoprolol Succinate, showing the molecular arrangement including aromatic ring, hydroxyl, methoxy groups, and succinate moiety in a detailed bond-line format.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.